1. Home
  2. OMIC

OMIC

Singular Genomics Systems Inc.

Logo Singular Genomics Systems Inc.

Health Care

Medical/Dental Instruments

Nasdaq

as 04-17-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. The G4 Sequencing Platform is designed to target the NGS market. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others.

Founded: 2016 Country:
United States
United States
Employees: N/A City: SAN DIEGO
Market Cap: 37.8M IPO Year: 2021
Target Price: $0.68 AVG Volume (30 days): 114.1K
Analyst Decision: Hold Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.30 EPS Growth: N/A
52 Week Low/High: $0.31 - $1.21 Next Earning Date: 05-07-2024
Revenue: $2,911,000 Revenue Growth: 280.52%
Revenue Growth (this year): -15.25% Revenue Growth (next year): 779.21%

Share on Social Networks: